Market
How many patients will be treated with Russia's AI-assisted cancer vaccine by end of 2025?
2
Resolution / Starting Odds
Less than 1,000 • 25%
1,000 to 5,000 • 25%
5,001 to 10,000 • 25%
More than 10,000 • 25%
Reports from Russian Ministry of Health or healthcare facilities
Story
Russia's AI-Assisted Cancer Vaccine, Targeting Melanoma, Set for Approval in August and Treatments in September 2025
Jan 27, 2025, 04:20 AM
Russia is set to begin treatments using a groundbreaking AI-assisted cancer vaccine by September 2025, according to the Ministry of Health. The personalized vaccine, designed to target melanoma and assist post-treatment patients, can be created within a week for individual patients. Alexander Gintsburg, director of the Gamaleya Center, confirmed that the vaccine is expected to receive approval in August 2025. The use of artificial intelligence will facilitate the analysis of tumor parameters, allowing specialists to tailor the vaccine specifically to each patient's needs.
View original story
Similar markets
Less than 10,000 • 25%
10,000 to 50,000 • 25%
More than 100,000 • 25%
50,001 to 100,000 • 25%
Less than 10,000 • 25%
More than 100,000 • 25%
50,001 to 100,000 • 25%
10,000 to 50,000 • 25%
10,000 to 50,000 • 25%
More than 100,000 • 25%
50,001 to 100,000 • 25%
Less than 10,000 • 25%
100,000 to 199,999 doses • 25%
200,000 to 299,999 doses • 25%
300,000 or more doses • 25%
Less than 100,000 doses • 25%
500,001 to 1,000,000 doses • 25%
More than 1,000,000 doses • 25%
100,000 to 500,000 doses • 25%
Less than 100,000 doses • 25%
50,001 to 100,000 • 25%
Less than 10,000 • 25%
10,000 to 50,000 • 25%
More than 100,000 • 25%
Below 70% efficacy • 25%
80-90% efficacy • 25%
70-79% efficacy • 25%
Above 90% efficacy • 25%
Asia • 25%
Both Europe and Asia • 25%
None • 25%
Europe • 25%
Trials delayed • 25%
Unsuccessful • 25%
Successful with minor issues • 25%
Successful with no major issues • 25%
Other • 25%
Lung Cancer • 25%
Breast Cancer • 25%
Colon Cancer • 25%